From October 23-25, 2023, the second International Congress on Clinical Immunology and Allergy (ICIA) was grandly held in Boston, USA. Dr. Wenqing Yang, our company's CSO, attended the event as a member of the Scientific Committee on behalf of ClinBridge Bio.
27
2023
/
10
Dr. Yang Wenqing, founder and CSO of ClinBridge Bio, was invited to organize and delivered a keynote speech at the International Conference on Cancer and Oncology Research held on June 19-20, 2023, in Rome, Italy.
22
2023
/
06
The Fifth Global Infectious Diseases Conference (WCID) was held from October 23rd to 25th, 2023, in Boston, USA. Dr. WenQing Yang, co-founder and CSO of our company, attended this important event as a member of the Scientific Committee and delivered a keynote speech. The three-day conference featured nearly 100 academic presentations by experts and scholars from around the world, including prominent U.S. virology, infectious diseases, and public health experts such as Dr. Ranjan Ramasamy, Dr. Astagneau Pascal, Dr. Yongqing Li, and Professor Astagneau Pascal from France. As a member of the Scientific Committee, Dr. Yang also chaired the conference's scientific section.
27
2023
/
10
From March 27th to 29th, 2023, the Third World Cancer Research Conference (SWCR 2023) was held at the Grand Hyatt in Tokyo. The event featured 75 distinguished guest speakers from 22 countries around the world, including Dr. Karim Azer, Vice President of Axella Therapeutics from the USA; Mr. Stephan Baumann, Manager of the Infectious Disease Division at Agilent Technologies, USA; Dr. Qian H.Li, Vice President of Biostatistics and Consulting at SDC, USA; Dr. Olivier Pardo, Team Leader at Imperial College London, UK; and Dr. Michael Castro, a Neuro-Oncologist and Medical Oncologist from Personalized Cancer Medicine Inc., USA.
29
2023
/
03
联科
Official Public Number
Copyright©2023 Nanjing Yunqiao Purui Biotechnology Co., Ltd.
